3Hudson BG, Tryggvason K, Sundaramoorthy M, et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med, 2003, 348: 2543-2556.
4Gharavi AE, Reiber H. Affinity and avidity of autoantibodies. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. Elsevier Science B.V., 1996. 13-23.
5Friguet B, Chaffotte AF, Djavadi-Ohaniance L, et al. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbant assay. J Immunol Meth, 1985, 77: 305-319.
6Marriott JB, Oliveira DBG. Serial functional affinity of autoantibodies in anti-glomerular basement membrane disease. Clin Exp Immunol, 1994, 95: 498-501.
7Rutgers A, Meyers KEC, Canziani G, et al. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to α3(IV)NC1 collagen. Kidney Int, 2000, 58: 115-122.
8Dougan T, Levy JB, Salama A, et al. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor. Clin Exp Immunol, 2002, 128: 555-561.
9Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titer and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract, 2003, 94: c59-c68.
